OncoSynergy scores Series A funding
OncoSynergy, an oncology therapeutics spin-out from UCSF, has raised an undisclosed amount of Series A funding. Connecticut Innovations led the round with participation from other investors that included NLabs Inc and Korea Information & Communication Co. Ltd.
4 May 2018•1 min read
